These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10328573)

  • 21. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    McConkey B
    Curr Opin Rheumatol; 1991 Jun; 3(3):348-54. PubMed ID: 1679342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
    Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
    Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
    Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
    Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
    Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of rheumatoid arthritis.
    Zurier RB; DeMarco DM; Liu NY
    N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
    [No Abstract]   [Full Text] [Related]  

  • 27. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
    Rasch LA; van Tuyl LH; Lems WF; Boers M
    Neuroimmunomodulation; 2015; 22(1-2):51-6. PubMed ID: 25227967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of rheumatoid arthritis.
    Stohl W; Arkfeld DG
    N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
    [No Abstract]   [Full Text] [Related]  

  • 29. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
    Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions.
    Haagsma CJ; van Riel PL; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():104-8. PubMed ID: 8535640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of sulphasalazine and methotrexate in the management of rheumatoid arthritis--view based on personal clinical experience.
    Shiroky JB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():109-12. PubMed ID: 8535641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The goal for the treatment of rheumatoid arthritis should be remission].
    Möttönen T; Mäkinen H; Puolakka K
    Duodecim; 2010; 126(12):1457-64. PubMed ID: 20617749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
    Kremer JM
    Ann Intern Med; 2001 Apr; 134(8):695-706. PubMed ID: 11304108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A survey on therapy strategies for rheumatoid arthritis in Chinese rheumatologists].
    Wang M; Zhang L; Peng Z; Wang Y; Liu SY
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):375-379. PubMed ID: 32370467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid arthritis: new developments in the use of existing therapies.
    O'Dell JR; Scott DL
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():24-6. PubMed ID: 10646486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid arthritis: more aggressive approach improves outlook.
    Weinblatt ME
    Cleve Clin J Med; 2004 May; 71(5):409-13. PubMed ID: 15195775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
    Rantalaiho VM; Kautiainen H; Korpela M; Hannonen PJ; Leirisalo-Repo M; Möttönen T;
    Ann Rheum Dis; 2013 May; 72(5):786-8. PubMed ID: 23349132
    [No Abstract]   [Full Text] [Related]  

  • 39. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
    ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF
    Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.
    van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
    J Rheumatol; 2009 Jul; 36(7):1380-6. PubMed ID: 19487259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.